Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > Well Baxter, What you have to say about "partner" Spectral?

<< Previous

Bullboard Posts

Next >>

Comment by SouthernTierTomon May 20, 2022 3:12pm

167 Views

Post# 34699255

RE:Well Baxter, What you have to say about "partner" Spectral?

Bear in mind, We ( Spectral Medical - EDT.T, formerly SDI.T ) were mentioned in their ( Baxter Medical ) financials after they gave us 5M USD for a prime position in the que to be our distributor. Fellow members of STIG intend to call in next week and inquire about their level of satifaction ( Hopefully their name isn`t Mick ) for their 5M USD spend. Peanuts really, however the activation of the 4,000 Baxter Prismax machines here in the US may or may not be of interest to this focussed group.

Bear in mind II, we signed a tidy little deal with Fresenius Medical of Germainy for them to distribute our EAA product. This important deal was annouced the day Valeant crash landed. Almost like `they new`..you Canadiens...what an honorable bunch ; - )

Baxter to Host 2022 Investor Conference

2022-05-10 16:15 ET - News Release

DEERFIELD, Ill. -- (Business Wire)

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host an investor conference on Wednesday, May 25, 2022 in Glenview, Ill. Chairman and CEO Joe Almeida and other members of Baxter's management team will provide a closer look at the company's growth strategy, innovation pipeline and longer term financial outlook. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter's pipeline beginning at 8:00 a.m. CT and will again be available following the conclusion of the formal presentations. Presentations by members of the Baxter management team will commence at 8:30 a.m. CT.

The meeting and accompanying slides will be webcast live by Q4 Inc. and will be accessible from Baxter's corporate website at: www.baxter.com. To participate in either in person or via Webcast please follow this link https://event.on24.com/wcc/r/3759007/B8AF902BE0A0CEF4BB9D52CDD5988048 to register and receive the details for the event.

The meeting will be recorded by Baxter as copyrighted material and cannot be recorded or rebroadcast without Baxter's permission.

About Baxter

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.